|
SEC24A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.25479999951916E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.15429999999417E-05 |
| Normal-vs-Stage2 |
2.777400E-03 |
| Normal-vs-Stage3 |
2.857000E-03 |
| Normal-vs-Stage4 |
2.791600E-04 |
| Stage1-vs-Stage2 |
2.333800E-01 |
| Stage1-vs-Stage3 |
4.532600E-01 |
| Stage1-vs-Stage4 |
2.326600E-01 |
| Stage2-vs-Stage3 |
6.575200E-01 |
| Stage2-vs-Stage4 |
7.753600E-01 |
| Stage3-vs-Stage4 |
8.007400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.07089999990384E-08 |
| Normal-vs-AfricanAmerican |
6.995600E-01 |
| Normal-vs-Asian |
2.485200E-01 |
| Caucasian-vs-AfricanAmerican |
1.96959999998469E-06 |
| Caucasian-vs-Asian |
9.969000E-01 |
| AfricanAmerican-vs-Asian |
6.380300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.41200000000919E-06 |
| Normal-vs-Female |
2.00819999999213E-05 |
| Male-vs-Female |
9.256200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.668400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.60562000000031E-05 |
| Normal-vs-Age(61-80Yrs) |
1.78142999999187E-05 |
| Normal-vs-Age(81-100Yrs) |
5.433900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.958200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.740500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.251770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.082200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.556200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.593200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.274970E-01 |
| Normal-vs-Grade 2 |
8.38220000000112E-05 |
| Normal-vs-Grade 3 |
1.93438999999129E-05 |
| Normal-vs-Grade 4 |
1.615760E-03 |
| Grade 1-vs-Grade 2 |
8.678600E-01 |
| Grade 1-vs-Grade 3 |
9.133800E-01 |
| Grade 1-vs-Grade 4 |
8.179600E-01 |
| Grade 2-vs-Grade 3 |
7.718000E-01 |
| Grade 2-vs-Grade 4 |
9.542600E-01 |
| Grade 3-vs-Grade 4 |
7.570400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.45100000015219E-07 |
| Normal-vs-ccB subtype |
5.214600E-04 |
| ccA subtype-vs-ccB subtype |
5.589200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.5423599999953E-05 |
| Normal-vs-N1 |
4.863500E-02 |
| N0-vs-N1 |
4.790400E-01 |
|
|
